Core Points - The implementation rules for cumulative voting at Cyrus Medical Technology Group are established to protect the rights of minority shareholders and ensure compliance with relevant laws and regulations [1][4] - Cumulative voting will be applied when the company elects or replaces directors, particularly when a single shareholder or their concerted parties hold 30% or more of the voting shares and when electing two or more independent directors [1][2] Summary by Sections Cumulative Voting System - The cumulative voting system allows each share to have voting rights equal to the number of directors to be elected, enabling shareholders to concentrate their votes on one candidate or distribute them among several [1][2] - The voting process requires shareholders to indicate their chosen directors and the number of votes allocated to each on a single ballot [2][4] Voting Procedures - If the total votes used by a shareholder exceed their legal voting rights, the ballot will be considered invalid unless corrected [2][4] - The counting of votes will be conducted by the monitoring personnel, and the elected directors must receive more than half of the votes from the attending shareholders [2][4] Information Disclosure - The company is obligated to disclose information regarding the voting system used, the absolute number of votes received by elected directors, and any other relevant matters deemed necessary by the board or independent directors [4] Nomination and Implementation - The nomination procedures for director candidates will follow the company's articles of association [4] - The implementation rules will take effect upon approval by the company's shareholders' meeting and will be interpreted and revised by the board of directors [4]
塞力医疗: 累积投票实施细则(2025年8月)